Glioblastoma is a refractory malignant tumor that requires
novel
therapeutic strategies for effective treatment. We have previously
reported that JCI-20679 (1), an analog of annonaceous
acetogenins, shows potent antitumor activity against glioblastomas.
However, the synthesis of 1 requires 23 steps, including
16 steps for the preparation of a tetrahydrofuran (THF) moiety. This
study reports the design and synthesis of 11 analogs with a triethylene
glycol moiety in place of the THF moiety in 1. Among
these, the analog 2k with an n-decyl
chain exhibited potent inhibitory activity against the growth of glioblastoma
stem cells by inhibiting mitochondrial function and synergistically
enhancing the effect of temozolomide (TMZ). Furthermore, 2k significantly suppressed tumor growth without critical toxicity in vivo. Hence, this study presents novel potential anticancer
agents and a strategy for the development of these agents that can
be produced easily.